Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.

JAMA Ophthalmol · 2025 · PMC11886866 · PMID 40048178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The PDS also showed a trend toward improved CST vs control (adjusted mean baseline change, –18.8 μm vs +2.5 μm, respectively, at week 52).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.